Radiopharm Theranostics Ltd (RADX) stock
Close on Nov 12, 2026Market cap $9.33MP/E –Yield –
Radiopharm Theranostics statistics
61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 1.02
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 47.7%
- 10.9%
- Float
- 2.57B
- 49M
- Shares Held by Insiders
- 27.5%
- 12.1%
- Shares Held by Institutions
- 1.44%
- 56.4%
Short sellingIndustry
- Short Interest
- 134,355
- –
- Short Interest Change
- -5.29%
- -0.76%
- Days to Cover
- 4.53
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $16.25
- –
- 52-Week Low
- $0.74
- –
- 20-Day Moving Average
- $0.95
- –
- 50-Day Moving Average
- $1.32
- –
- 200-Day Moving Average
- $3.49
- –
- Average True Range (14)
- $0.15
- –
- Price Change (1 Week)
- -11.1%
- 1.51%
- Price Change (1 Month)
- -29.5%
- -2.35%
- Price Change (3 Months)
- -69.1%
- -21.1%
- Price Change (6 Months)
- -83.3%
- -22.6%
- Price Change (YTD)
- -84.9%
- -22.6%
- Price Change (1 Year)
- -82.8%
- -20.7%
- Average Volume (10 Days)
- 67,736
- –
- Average Volume (20 Days)
- 49,838
- –
- Average Volume (90 Days)
- 76,983
- –
- Relative Volume
- 0.43
- 0.79
- Relative Strength Index (14)
- 32.1
- 44.7
- Volatility (1 Year)
- 170.5%
- 80.4%
- Beta (5 Years)
- 1.02
- 1.07
MarginsIndustry
- Pretax Margin
- -2055.6%
- -11.8%
- EBITDA Margin
- -1953.8%
- -27.7%
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -137.7%
- -38.0%
Financial positionIndustry
- Current Ratio
- 1.16
- 3.30
- Quick Ratio
- 1.14
- 2.42
- Interest Coverage
- -505.21
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -23.8%
- 7.01%
- Revenue Growth (3Y CAGR)
- 111.5%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.04
- 0.40
- Revenue Per Employee
- $1.38M
- $429.29K
- Employee Count
- 2
- 75
- WACC
- 10.1%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$56.90M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $4.14M
- $17.46M
- Net Cash Per Share
- $0.00
- $0.72
- Working Capital
- $3.03M
- $79.47M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Buyback Yield
- -379.1%
- -0.73%
- Shareholder Yield
- -379.1%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $112.40K
- $2.93M
- Income Tax
- $54.44K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -2.86
- 0.30
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | RADX | S&P 500 | Difference | RADX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -28.8% | -2.7% | −26.1 pts | ||
| 3 months | -71.6% | -1.7% | −69.8 pts | ||
| Year to date | -84.9% | +11.9% | −96.8 pts | ||
| 1 year | -83.1% | +12.0% | −95.1 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M RADX shares were sold short on Oct 30, 2026, down 5.3% from the previous report. At recent volumes it would take 4.5 days to buy them back. Over the last 20 sessions, 55.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 134,355 | -5.3% | 29,687 | 4.5 |
| Oct 15, 2026 | 141,864 | +313.3% | 60,205 | 2.4 |
| Sep 30, 2026 | 34,322 | -18.7% | 55,282 | 1.0 |
| Sep 15, 2026 | 42,220 | +38.8% | 42,984 | 1.0 |
| Aug 31, 2026 | 30,426 | +12.7% | 83,256 | 1.0 |
| Aug 14, 2026 | 27,000 | -63.6% | 50,747 | 1.0 |
| Jul 31, 2026 | 74,099 | +10.6% | 194,680 | 1.0 |
| Jul 15, 2026 | 66,998 | +7.1% | 19,228 | 3.5 |
| Jun 30, 2026 | 62,568 | +45.2% | 24,562 | 2.5 |
| Jun 15, 2026 | 43,083 | -15.4% | 24,795 | 1.7 |
| May 29, 2026 | 50,928 | +7.6% | 23,339 | 2.2 |
| May 15, 2026 | 47,338 | +32.3% | 58,180 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?